Molecular imaging contrast media for visualization of liver function

Magnetic Resonance Imaging

Volumn 28, Issue 5, 2010, Pages 708-715

  Yoshinori, Matsuoka ^a   Masaharu, Murata ^a   Yuri, Huzisaki ^a   Sayoko, Narahara ^a   Nao, Shinzato ^a   Makoto, Hashizume ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; CONTRAST MEDIUM; FLUORESCEIN ISOTHIOCYANATE; GADOLINIUM PENTETATE; GALACTOSE; LACTOSE; MEMBRANE PROTEIN; NANOPARTICLE; RECEPTOR ANTIBODY;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; CANCER CELL; CELL INTERACTION; CHEMICAL STRUCTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG TARGETING; IN VITRO STUDY; LIVER CELL; LIVER DISEASE; LIVER FUNCTION; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING; ANIMAL; CELL LINE; CYTOLOGY; GENETIC PROCEDURES; IMAGE ENHANCEMENT; LIVER FUNCTION TEST; METABOLISM; PROCEDURES;

ANIMALS; ASIALOGLYCOPROTEIN RECEPTOR; CELL LINE; CONTRAST MEDIA; HEPATOCYTES; IMAGE ENHANCEMENT; LIVER FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MOLECULAR PROBE TECHNIQUES; RATS;

RATTUS;

EID: 77952958580     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2010.02.003     Document Type: Article

References (14)

1. Caravan P., Ellison J.J., McMurry T.J., et al. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999, 99:2293-2352.
2. Whitney W.S., Herfkens R.J., Jeffrey R.B., et al. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. Radiology 1993, 189:863-870.
3. Hamm B., Thoeni R.F., Gould R.G., et al. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 1994, 190:417-423.
4. Clement O., Frija G., Chambon C., et al. Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging. Radiology 1991, 180:31-36.
5. Reimer P., Tombach B. Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 1998, 8:1198-1204.
6. Schuhmann-Giampieri G., Schmitt-Willich H., Press W.R., et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992, 183:59-64.
7. Zech C.J., Grazioli L., Breuer J., et al. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 2008, 43:504-511.
8. Stockert R.J., Morell A.G., Ashwell G. Structural characteristics and regulation of the asialoglycoprotein receptor. Targeted Diagn Ther 1991, 4:41-64.
9. Kohgo Y., Kondo H., Mogi Y., et al. Mechanism and clinical significance of soluble hepatic cell-surface receptors. Targeted Diagn Ther 1991, 4:305-319.
10. Sawamura T., Nakada H., Hazama H., et al. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma. Gastroenterology 1984, 87:1217-1221.
11. Sawamura T., Kawasato S., Tsuda M., et al. Clinical application of the measurement of serum asialoglycoproteins to estimate residual liver function in patients with chronic liver diseases with or without hepatocellular carcinoma. Gastroenterol Jpn 1985, 20:201-208.
12. Onodera Y., Takahashi K., Togashi T., et al. Clinical assessment of hepatic functional reserve using 99mTc DTPA galactosyl human serum albumin SPECT to prognosticate chronic hepatic diseases-validation of the use of SPECT and a new indicator. Ann Nucl Med 2003, 17:181-188.
13. Berg K.J., Lundby B., Reinton V., et al. Gadodiamide in renal transplant patients: effects on renal function and usefulness as a glomerular filtration rate marker. Nephron 1996, 72:212-217.
14. Kellar K.E., Henrichs P.M., Hollister R., et al. High relaxivity linear Gd(DTPA)-polymer conjugates: the role of hydrophobic interactions. Magn Reson Med 1997, 38:712-716.